A股異動 | 安居寶跌停 深交所質疑其配合股東減持而炒作股價
格隆匯2月19日丨此前六連板的安居寶(300155.SZ)今日高開7%,開盤後閃崩跌停,封單逾11萬手。現報9.67元,暫成交6億元,最新總市值52億元。安居寶日前發公告稱,收深交所問詢函。深交所注意到安居寶高級管理人員黃偉寧於2月14日通過集中競價方式減持了公司股份29萬股,因此,深交所要求補充披露公司董事、監事、高級管理人員、持股5%以上股東近1個月買賣公司股票的情況,説明是否存在為減持而炒作股價的情形。還要求安居寶核實説明除前期發佈的擬籌劃非公開發行股票事項外,公司是否存在其他籌劃中的重大事項,是否存在應披露未披露的重大信息,是否存在違反信息披露公平原則的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.